Highbridge Capital Management’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-8,254
Closed -$277K 1659
2016
Q1
$277K Buy
+8,254
New +$260K ﹤0.01% 1211
2015
Q4
Sell
-10,275
Closed -$346K 1730
2015
Q3
$324K Buy
+10,275
New +$501K 0.01% 1206
2014
Q4
Sell
-16,980
Closed -$302K 1375
2014
Q3
$302K Buy
+16,980
New +$347K ﹤0.01% 999

Other funds holding PGEN

Highbridge Capital Management's PGEN Position: Q2 2016 in Review

Highbridge Capital Management sold out of Precigen (PGEN) in Q2 2016, closing a stake of 8,254 shares — an estimated $277K sold.

Highbridge Capital Management first reported a position in PGEN in Q3 2014 and held it in 3 quarters. The position peaked at $324K in Q3 2015. 169 funds tracked by Wall St. Rank hold PGEN as of Q2 2016.

  • Highbridge Capital Management reported no remaining Precigen position as of Q2 2016 after selling out during the quarter.
  • Highbridge Capital Management sold 8,254 Precigen shares in Q2 2016, an estimated $277K.
  • Highbridge Capital Management first reported a position in Precigen in Q3 2014 and held it in 3 quarters.
  • Highbridge Capital Management's Precigen position peaked at $324K in Q3 2015.
  • 169 funds tracked by Wall St. Rank held Precigen as of Q2 2016.

Based on Highbridge Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.